Medicine
Oxybutynin 5 mg tablet
Oxybutynin 5 mg tablet is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Oxybutynin
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 121 more
- Manufacturers
- Strides PharmaIndiaAvet PharmaceuticalsIndiaRising Pharma HoldingsANI PharmaceuticalsKVK-TechLeading PharmaTeva PharmaceuticalsUpsher-Smith LaboratoriesTruPharmaVerityrx28 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04BD04 Oxybutynin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 September 1990
- Identifiers
- RxCUI 863664, 863758, 863636DailyMed set ID 73d715dc-868d-4194-b668-4c39ababa698, 39a2d144-0c10-4aec-9fa4-0adc24b332eb, 7c497c6c-2448-2c80-e053-2991aa0ab8c7 +37NDC 23155-913, 50090-4622, 52817-260 +37Application ANDA211682, ANDA209335, ANDA210125 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 28 labelers. The register lists 124 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 23155-810-01 | Avet PharmaceuticalsIndia | 31 January 2022 |
| 500 tablet in 1 bottle | 23155-810-05 | Avet PharmaceuticalsIndia | 31 January 2022 |
| 1000 tablet in 1 bottle | 23155-810-10 | Avet PharmaceuticalsIndia | 31 January 2022 |
| 100 tablet in 1 bottle, plastic | 23155-913-01 | Avet PharmaceuticalsIndia | 1 June 2026 |
| 500 tablet in 1 bottle, plastic | 23155-913-05 | Avet PharmaceuticalsIndia | 1 June 2026 |
| 1000 tablet in 1 bottle, plastic | 23155-913-10 | Avet PharmaceuticalsIndia | 1 June 2026 |
| 100 tablet in 1 bottle, plastic | 64380-162-01 | Strides PharmaIndia | 30 September 2022 |
| 500 tablet in 1 bottle, plastic | 64380-162-02 | Strides PharmaIndia | 4 April 2022 |
| 1000 tablet in 1 bottle, plastic | 64380-162-03 | Strides PharmaIndia | 30 September 2022 |
| 60 tablet in 1 bottle | 64380-781-03 | Strides PharmaIndia | 20 December 2024 |
| 90 tablet in 1 bottle | 64380-781-05 | Strides PharmaIndia | 20 December 2024 |
| 100 tablet in 1 bottle | 64380-781-06 | Strides PharmaIndia | 20 December 2024 |
| 500 tablet in 1 bottle | 64380-781-07 | Strides PharmaIndia | 20 December 2024 |
| 1000 tablet in 1 bottle | 64380-781-08 | Strides PharmaIndia | 20 December 2024 |
| 100 tablet in 1 bottle | 64980-431-01 | Rising Pharma Holdings | 1 February 2018 |
| 1000 tablet in 1 bottle | 64980-431-10 | Rising Pharma Holdings | 1 February 2018 |
| 500 tablet in 1 bottle | 64980-431-50 | Rising Pharma Holdings | 1 February 2018 |
| 100 tablet in 1 bottle | 64980-679-01 | Rising Pharma Holdings | 18 July 2026 |
| 1000 tablet in 1 bottle | 64980-679-10 | Rising Pharma Holdings | 27 April 2026 |
| 500 tablet in 1 bottle | 64980-679-50 | Rising Pharma Holdings | 27 April 2026 |
| 100 tablet in 1 bottle | 70954-005-10 | ANI Pharmaceuticals | 15 November 2017 |
| 500 tablet in 1 bottle | 70954-005-20 | ANI Pharmaceuticals | 15 November 2017 |
| 1000 tablet in 1 bottle | 70954-005-30 | ANI Pharmaceuticals | 15 November 2017 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 70954-005-50 | ANI Pharmaceuticals | 20 August 2021 |
| 100 tablet in 1 bottle, plastic | 10702-201-01 | KVK-Tech | 22 December 2017 |
| 1000 tablet in 1 bottle, plastic | 10702-201-10 | KVK-Tech | 22 December 2017 |
| 500 tablet in 1 bottle, plastic | 10702-201-50 | KVK-Tech | 22 December 2017 |
| 100 tablet in 1 bottle | 69315-182-01 | Leading Pharma | 1 November 2019 |
| 500 tablet in 1 bottle | 69315-182-05 | Leading Pharma | 1 November 2019 |
| 1000 tablet in 1 bottle | 69315-182-10 | Leading Pharma | 1 November 2019 |
| 100 tablet in 1 bottle | 50111-456-01 | Teva Pharmaceuticals | 30 September 1990 |
| 500 tablet in 1 bottle | 50111-456-02 | Teva Pharmaceuticals | 30 September 1990 |
| 1000 tablet in 1 bottle | 50111-456-03 | Teva Pharmaceuticals | 30 September 1990 |
| 100 tablet in 1 bottle, plastic | 52817-260-10 | TruPharma | 1 January 2019 |
| 500 tablet in 1 bottle, plastic | 52817-260-50 | TruPharma | 1 January 2019 |
| 100 tablet in 1 bottle | 0832-0038-00 | Upsher-Smith Laboratories | 7 November 2011 |
| 1000 tablet in 1 bottle | 0832-0038-10 | Upsher-Smith Laboratories | 7 November 2011 |
| 500 tablet in 1 bottle | 0832-0038-50 | Upsher-Smith Laboratories | 7 November 2011 |
| 1 tablet in 1 pouch | 83939-0022-1 | Verityrx | 3 November 2025 |
| 50 pouch in 1 box, unit-dose / 1 tablet in 1 pouch | 83939-0022-2 | Verityrx | 3 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Oxybutynin
Clinical summary
Oxybutynin is a cholinergic muscarinic antagonist indicated for the treatment of overactive bladder in men with symptoms of urge urinary incontinence, urgency, and frequency. It is available as extended-release tablets, tablets and oral solution for transdermal use. MedsAcross supplies Oxybutynin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OxybutyninFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OXYTROL prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Kentera (previously Oxybutynin Nicobrand): European public assessment report (EPAR) · European Medicines Agency
Need Oxybutynin 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.